BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8592942)

  • 1. Effects of extracellular calcium on insulin-like growth factor II in human bone cells.
    Honda Y; Fitzsimmons RJ; Baylink DJ; Mohan S
    J Bone Miner Res; 1995 Nov; 10(11):1660-5. PubMed ID: 8592942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions.
    Kanzaki S; Baxter RC; Knutsen R; Baylink DJ; Mohan S
    J Bone Miner Res; 1995 Jun; 10(6):854-8. PubMed ID: 7572308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-II receptor number is increased in TE-85 osteosarcoma cells by combined magnetic fields.
    Fitzsimmons RJ; Ryaby JT; Magee FP; Baylink DJ
    J Bone Miner Res; 1995 May; 10(5):812-9. PubMed ID: 7639117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that the inhibition of TE85 human bone cell proliferation by agents which stimulate cAMP production may in part be mediated by changes in the IGF-II regulatory system.
    Mohan S; Baylink DJ
    Growth Regul; 1991 Sep; 1(3):110-8. PubMed ID: 1726835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of mitogenic action of aluminum ion on human bone cells: potential involvement of the insulin-like growth factor regulatory system.
    Lau KH; Utrapiromsuk S; Yoo A; Mohan S; Strong DD; Baylink DJ
    Arch Biochem Biophys; 1993 Jun; 303(2):267-73. PubMed ID: 7685579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization, regulation, and function of specific cell membrane receptors for insulin-like growth factor I on bone endothelial cells.
    Fiorelli G; Orlando C; Benvenuti S; Franceschelli F; Bianchi S; Pioli P; Tanini A; Serio M; Bartucci F; Brandi ML
    J Bone Miner Res; 1994 Mar; 9(3):329-37. PubMed ID: 8191926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of insulin-like growth factors to cultured rat calvarial cells with differing biologic responses.
    Cantrell PR; Frolik CA; Ellis LF; Williams DC
    J Bone Miner Res; 1991 Aug; 6(8):851-7. PubMed ID: 1664647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: implications in bone cell physiology.
    Durham SK; Kiefer MC; Riggs BL; Conover CA
    J Bone Miner Res; 1994 Jan; 9(1):111-7. PubMed ID: 7512304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dibutyryl cyclic adenosine monophosphate differentially regulates cell proliferation in low and high alkaline phosphatase SaOS-2 human osteosarcoma cells: evidence for mediation by the insulin-like growth factor-II system.
    Mohan S; Strong DD; Hilliker S; Malpe R; Lee K; Farley J; Baylink DJ
    J Cell Physiol; 1993 Sep; 156(3):462-8. PubMed ID: 7689570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors.
    Barreca A; De Luca M; Del Monte P; Bondanza S; Damonte G; Cariola G; Di Marco E; Giordano G; Cancedda R; Minuto F
    J Cell Physiol; 1992 May; 151(2):262-8. PubMed ID: 1374070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the regulation of insulin-like growth factor binding protein 3 secretion in human osteosarcoma cells in vitro.
    Nakao Y; Hilliker S; Baylink DJ; Mohan S
    J Bone Miner Res; 1994 Jun; 9(6):865-72. PubMed ID: 7521561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
    Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
    Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro.
    Camacho-Hubner C; McCusker RH; Clemmons DR
    J Cell Physiol; 1991 Aug; 148(2):281-9. PubMed ID: 1715344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein 2 increases insulin-like growth factor I and II transcripts and polypeptide levels in bone cell cultures.
    Canalis E; Gabbitas B
    J Bone Miner Res; 1994 Dec; 9(12):1999-2005. PubMed ID: 7872067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
    Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
    Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
    J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-I inhibits the progression of human U-2 OS osteosarcoma cells towards programmed cell death through interaction with the IGF-I receptor.
    Herzlieb N; Gallaher BW; Berthold A; Hille R; Kiess W
    Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):71-7. PubMed ID: 10726973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
    Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
    Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-I and human lung fibroblast-derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitro.
    Ankrapp DP; Bevan DR
    Cancer Res; 1993 Jul; 53(14):3399-404. PubMed ID: 8391925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.